Goldman Sachs has won its fourth drugs mandate in a month after advising a US company on its sale to Merck, the German pharmaceuticals company.

Goldman is advising Sirna Therapeutics, a US biotechnology company on its $1.1bn (€865m) sale to Merck according to a Sirna spokesman. JP Morgan is Sirna's usual adviser according to Standard & Poor's data provider Capital IQ.

Shanny Basar in New York

Goldman Sachs

JP Morgan

Morgan Stanley

Gilead Sciences

UBS promotes Hannon to UK M&A head as shake-up continues

UBS launches European strategy dealmaking group, shakes up country heads

Goldman Sachs names new ECM leadership in Europe after departures

Trading Places: Goldman’s ECM shake-up, Latham’s latest raid

https://images.fnlondon.com/im-329118?size=1.5

Find out who is on the move in the City and beyond this week

Sidley Austin raids Latham & Watkins for 10-lawyer team in London

https://images.fnlondon.com/im-38645354?size=1.5

CDPQ hires Sharon White to lead push in Europe

https://images.penews.com/im-05261766?size=1.5

Former chair of the John Lewis Partnership is joining the Canadian pension fund giant early next year

One of the top investors in Adani Group launched an on-market share buyback to protect its share price against the contagion from a U.S. investigation into the Indian conglomerate.

GQG Launches Buyback After Stock Tumbles on Adani Probe

The president-elect floated the idea during a Wednesday meeting with the former Fed governor.

By Brian Schwartz, Vivian Salama and Andrew Restuccia

Trump Considers Warsh Serving as Treasury Secretary—and Then Fed Chair

The U.S. auditing watchdog voted to require certain audit firms to disclose eight new metrics ranging from auditor turnover to partner involvement and restatement history.

Large Accounting Firms Will Have to Submit Financial Statements to U.S. Regulator

The AI titan will maintain its strong lead, but complicated product rollouts, sky-high expectations and the China threat add complications to growth potential.

Nvidia Is on Top but Does It Have Anywhere to Go but Down?

Research group GfK’s measure of consumer confidence climbed to minus 18 in November’s survey from minus 21 in October.

U.K. Consumers Cheerier Ahead of Holidays as Budget, U.S. Election Jitters Fade

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

https://www.wsj.com/?type=allesseh_content_full_list

https://www.fnlondon.com/client

MY ACCOUNT

ABOUT

SECTIONS

unbolded

Goldman stacks up pharma deals

Financial News